| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
An individualized, trauma-sensitive, and holistic approach to addressing boys` emotional and behavioral issues, and educational, recreational, and vocational goals.
Tanita Corporation of America, Inc. is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
TriCore Reference Laboratories is a community-based, independent, clinical reference laboratory that provides full-service, state-of-the-art laboratory tests to health care professionals and their patients. Based in Albuquerque, N.M., with clients in New Mexico and across the US. TriCore offers more than 1,500 laboratory tests ranging from routine (such as cholesterol screens) to highly specialized (such as genetic testing). TriCore participates in scientific research through collaboration with the University of New Mexico and numerous national and international biotech firms.
First Class Solutions is a Maryland Heights, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.